drugset / Trial / NCT01648023

Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin

NCT01648023 ↗

Phase 2 Completed 49 enrolled Robert C. Martin
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to find out if the combination of trans-arterial chemoembolization (LC or ONCOZENE BEAD) plus infusional chemotherapy is safe and more effective than just receiving the infusional chemotherapy alone.

Timeline

Start
2012-07
Primary completion
2019-01
Completion
2019-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carboplatin Small molecule — —
Comparator Cisplatin Other / unclassified — —
Comparator Gemcitabine Small molecule — —